Symptom Improvements with Once-Daily Opicapone in Patients with Parkinson's Disease and Motor Fluctuations: Results from a Phase 3, Randomized Clinical Trial (BIPARK-1)

被引：0
|
作者：
Lew, M. [1 ]
Hauser, R. A. [2 ]
Ferreira, J. [3 ]
Poewe, W. [4 ]
Rascol, O. [5 ]
Olson, K. [6 ]
Farahmand, K. [6 ]
Siegert, S. [6 ]
Rocha, J. F. [7 ]
Soares-da-Silva, P. [7 ,8 ]
Liang, G. S. [6 ]
机构：
[1] Univ Southern Calif, Los Angeles, CA USA
[2] Univ S Florida, Tampa, FL USA
[3] Univ Lisbon, Lisbon, Portugal
[4] Med Univ Innsbruck, Innsbruck, Austria
[5] Toulouse Univ Hosp, Toulouse, France
[6] Neurocrine Biosci Inc, San Diego, CA USA
[7] BIAL Portela & Ca SA, Sao Mamede Do Coronado, Portugal
[8] Univ Porto, Porto, Portugal
来源：
MOVEMENT DISORDERS | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1
引用
收藏
页码：S2 / S2
页数：1
相关论文
共 50 条
  • [31] Opicapone in Clinical Practice in Parkinson's Disease UK Patients with Motor Fluctuations: Findings from the OPTIPARK Study
    Lees, A.
    Reichmann, H.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2021, 36 : S219 - S219
  • [32] Efficacy of opicapone in Parkinson's disease patients with 'early' motor fluctuations: NMSS analysis from the BIPARK-I double-blind experience
    Antonini, A.
    Ferreira, J.
    Poewe, W.
    Rascol, O.
    Gama, H.
    Arbe, E.
    Rocha, J-F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2018, 33 : S135 - S136
  • [33] Efficacy of opicapone in Parkinson's disease patients with 'early' motor fluctuations: Responder analyses from the BIPARK-I double-blind experience
    Ferreira, J.
    Lees, A.
    Poewe, W.
    Rascol, O.
    Santos, A.
    Arbe, E.
    Rocha, J-F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2018, 33 : S103 - S104
  • [34] Efficacy of opicapone in Parkinson's disease patients with 'early' motor fluctuations: Patient and Clinical Global Impression of Change from the BIPARK-I double-blind experience
    Rocha, J.
    Stocchi, F.
    Lees, A.
    Ferreira, J.
    Poewe, W.
    Rascol, O.
    Santos, A.
    Magalhaes, D.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2019, 34 : S79 - S79
  • [35] Efficacy of opicapone in Parkinson's disease patients with 'early' motor fluctuations: Patient and clinical global impression of change from the BIPARK-I double-blind experience
    Rocha, F.
    Stocchi, F.
    Lees, A.
    Ferreira, J.
    Poewe, W.
    Rascol, O.
    Santos, A.
    Magalhaes, D.
    Soares-da-Silva, P.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [36] Opicapone use in patients with Parkinson's disease with motor fluctuations: experience from a tertiary center
    Ojeda-Lepe, E.
    Munoz-Delgado, L.
    Jesus, S.
    Adarmes-Gomez, A. D.
    Macias-Garcia, D.
    Jaraba, M. V. Jimenez
    Zamora, B. Benitez
    Carrillo, F.
    Mir, P.
    MOVEMENT DISORDERS, 2022, 37 : S461 - S461
  • [37] Safety and Tolerability of Opicapone in Patients with Parkinson's Disease and Motor Fluctuations: Pooled Analysis of Two Phase 3 Studies
    Kremens, D.
    Poewe, W.
    Rascol, O.
    Olson, K.
    Farahmand, K.
    Siegert, S.
    McMicken, C.
    Rocha, J. F.
    Soares-da-Silva, P.
    Liang, G. S.
    MOVEMENT DISORDERS, 2019, 34 : S8 - S8
  • [38] Opicapone in Parkinson's Disease German Patients with Motor Fluctuations: Findings from the OPTIPARK Study
    Reichmann, H.
    Lees, A.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2021, 36 : S232 - S233
  • [39] Safety of opicapone in fluctuating Parkinson's disease patients: Results of the 1-year extension of study BIPARK I
    Santos, A.
    Ferreira, J.
    Lees, A.
    Stocchi, F.
    Rascol, O.
    Lopes, N.
    Gama, H.
    Rocha, J. F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2016, 31 : S641 - S641
  • [40] Opicapone as adjunct to levodopa in treated Parkinson's disease without motor complications: A randomized clinical trial
    Ferreira, Joaquim J.
    Rascol, Olivier
    Stocchi, Fabrizio
    Antonini, Angelo
    Moreira, Joana
    Castilla-Fernandez, Guillermo
    Rocha, Jose-Francisco
    Holenz, Joerg
    Poewe, Werner
    Epsilon Study investigator
    EUROPEAN JOURNAL OF NEUROLOGY, 2025, 32 (01)
12345